Dr. King is Chief Science and Business Officer as well as co-founder of BioAccel. Dr. King brings more than 23 years of experience in health technology, business, and policy management in both public and private sectors. Prior to starting BioAccel, Dr. King was the Vice President of Business and Strategic Partnerships at The Translational Genomics Research Institute (TGen) where he was responsible for alliance management, business development, and technology commercialization. Dr. King has in depth experience in creating and launching novel programs designed to transform new technologies from research discoveries into useful products and business opportunities. Dr. King is an expert in developing and executing novel strategies for integrating science and business. Dr. King has held several senior level positions at the National Institutes of Health, including: Associate Director of Intramural Research and Director of Technology Transfer at the National Human Genome Research Institute. Dr. King helped manage the development of several technology programs associated with the Human Genome Project. He shared responsibility for over 300 scientists. Dr. King has extensive experience in academia, government, and industry. He has been involved at various levels in the formation and launch of over ten biotech companies and currently serves on the boards of three. Dr. King is an adjunct faculty member at the W.P. Carey School of Business at Arizona State University. He is also an adjunct faculty member at the Translational Genomics Research Institute. Dr. King holds a Ph.D. in Biochemistry and Pharmacology from the University of California, Los Angeles and Riverside. He holds an MBA from Arizona State University, and certifications and training from the Haas School of Business at the University of California, Berkeley.